Chinook Therapeutics Inc. (KDNY)
NASDAQ: KDNY
· Real-Time Price · USD
40.39
0.09 (0.22%)
At close: Aug 10, 2023, 10:00 PM
Chinook Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -66.94M | -60.18M | -62.55M | -55.98M | -37.65M | -31.68M | 7.54M | -30.7M | -42.57M | -37.22M |
Depreciation & Amortization | 1.91M | 1.3M | 1.27M | 1.27M | 1.26M | 1.29M | 1.24M | 1.11M | 1.17M | 1.22M |
Stock-Based Compensation | 9.19M | 7.91M | 5.71M | 5.32M | 4.76M | 4.27M | 3.42M | 3.29M | 3.6M | 2.48M |
Other Working Capital | -11.3M | -995K | 5.97M | 7.25M | 4.03M | -8.37M | 1.5M | 3.5M | -4.1M | -1.52M |
Other Non-Cash Items | 3.43M | 2.63M | 8.92M | 9.21M | 1.61M | 490K | -32.19M | 1.86M | 12.89M | 3.13M |
Deferred Income Tax | -3.33M | n/a | 4.34M | n/a | n/a | 1.42M | 3.3M | -463K | -7.97M | n/a |
Change in Working Capital | -5.45M | -2.33M | 5.49M | 14.87M | -605K | -507K | -5.82M | 170K | -2.51M | 2.3M |
Operating Cash Flow | -61.2M | -50.67M | -36.83M | -25.31M | -30.62M | -24.72M | -22.5M | -24.73M | -27.43M | -28.08M |
Capital Expenditures | -619K | -927K | -683K | -369K | -227K | -374K | -381K | -753K | -150K | -594K |
Cash Acquisitions | n/a | -97.5M | -200.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -27.47M | -64.14M | -64.99M | -81.98M | -73.18M | -79.03M | -103.36M | -23.66M | -71.67M | -33.66M |
Sales Maturities Of Investments | 96.1M | 97.5M | 68.15M | 69.22M | 39.65M | 23.83M | 26M | 21.7M | 31.8M | 41.82M |
Other Investing Acitivies | n/a | 97.5M | 200.84M | n/a | n/a | n/a | n/a | n/a | n/a | 267K |
Investing Cash Flow | 68.01M | 32.43M | 2.47M | -13.13M | -33.76M | -55.57M | -77.74M | -2.71M | -40.02M | 7.83M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.01M | 21.27M | 23.69M | 18.83M | 107.14M | 1.76M | 173.61M | 259K | 35.08M | 580K |
Financial Cash Flow | 2.01M | 21.27M | 23.69M | 18.83M | 107.14M | 1.76M | 173.61M | 259K | 35.08M | 580K |
Net Cash Flow | 8.65M | 3.06M | -10.63M | -19.86M | 42.43M | -78.22M | 73.2M | -26.94M | -32.3M | -19.66M |
Free Cash Flow | -61.81M | -51.59M | -37.51M | -25.68M | -30.84M | -25.1M | -22.88M | -25.48M | -27.58M | -28.68M |